Recent discussions on X about Tempus AI, Inc. (TEM) have been notably active, with much of the conversation revolving around the company’s raised 2025 financial outlook and strong quarterly results. Many users are highlighting the boosted revenue and EBITDA projections as a sign of robust growth potential. Strategic partnerships have also been a focal point, fueling optimism among participants.
However, not all sentiments are uniformly positive, as some posts on X reflect concerns following a critical short report from earlier this year, which questioned the company’s revenue sources and leadership. Additionally, ahead of upcoming earnings, there’s a mix of technical analysis circulating, with some expressing bearish outlooks based on recent price trends. This blend of excitement and caution keeps the dialogue around TEM dynamic and engaging.
Note: This discussion summary was generated from an AI condensation of post data.
Tempus AI, Inc. Insider Trading Activity
Tempus AI, Inc. insiders have traded $TEM stock on the open market 194 times in the past 6 months. Of those trades, 0 have been purchases and 194 have been sales.
Here’s a breakdown of recent trading of $TEM stock by insiders over the last 6 months:
- ERIC P LEFKOFSKY (CEO and Chairman) has made 0 purchases and 64 sales selling 5,213,385 shares for an estimated $314,233,640.
- ERIK PHELPS (EVP & Chief Admin & Legal Off) has made 0 purchases and 19 sales selling 122,217 shares for an estimated $9,401,561.
- ANDREW POLOVIN (EVP and General Counsel) has made 0 purchases and 26 sales selling 105,118 shares for an estimated $7,728,085.
- JAMES WILLIAM ROGERS (Chief Financial Officer) has made 0 purchases and 22 sales selling 79,471 shares for an estimated $5,263,902.
- RYAN FUKUSHIMA (Chief Operating Officer) has made 0 purchases and 18 sales selling 75,688 shares for an estimated $4,345,098.
- SCOTT GOTTLIEB has made 0 purchases and 9 sales selling 55,675 shares for an estimated $2,674,142.
- RYAN M BARTOLUCCI (Chief Accounting Officer) has made 0 purchases and 7 sales selling 14,632 shares for an estimated $1,070,275.
- JENNIFER A DOUDNA has made 0 purchases and 8 sales selling 11,811 shares for an estimated $642,886.
- WAYNE A.I. FREDERICK has made 0 purchases and 6 sales selling 12,000 shares for an estimated $576,278.
- NADJA WEST has made 0 purchases and 10 sales selling 8,443 shares for an estimated $414,309.
- DAVID R EPSTEIN has made 0 purchases and 4 sales selling 1,980 shares for an estimated $100,365.
- THEODORE LEONSIS sold 770 shares for an estimated $51,020
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Tempus AI, Inc. Government Contracts
We have seen $5,785,617 of award payments to $TEM over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TUMOR NORMAL MATCHED GENOMIC TESTING SERVICES: $5,718,045
- DNA METHYLATION SERVICES FOR TELECONFERENCING EXERCISE STUDY IN HIV + PATIENTS: $67,572
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Tempus AI, Inc. Analyst Ratings
Wall Street analysts have issued reports on $TEM in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 06/30/2025
- Morgan Stanley issued a "Overweight" rating on 05/09/2025
- Needham issued a "Buy" rating on 05/07/2025
- BTIG issued a "Buy" rating on 04/21/2025
To track analyst ratings and price targets for Tempus AI, Inc., check out Quiver Quantitative's $TEM forecast page.
Tempus AI, Inc. Price Targets
Multiple analysts have issued price targets for $TEM recently. We have seen 7 analysts offer price targets for $TEM in the last 6 months, with a median target of $70.0.
Here are some recent targets:
- Subbu Nambi from Guggenheim set a target price of $75.0 on 06/30/2025
- Michael Ryskin from B of A Securities set a target price of $70.0 on 06/25/2025
- David Westenberg from Piper Sandler set a target price of $70.0 on 05/15/2025
- Tejas Savant from Morgan Stanley set a target price of $65.0 on 05/09/2025
- Ryan MacDonald from Needham set a target price of $70.0 on 05/07/2025
- Mark Massaro from BTIG set a target price of $60.0 on 04/21/2025
- Rachel Vatnsdal from JP Morgan set a target price of $55.0 on 02/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
